Skip to main content
. 2018 Oct 1;53(6):2433–2444. doi: 10.3892/ijo.2018.4580

Figure 2.

Figure 2

The prognostic significance of miR-103 in patients with HCC. (A) OS was compared between patients with HCC with a high expression level of miR-103 and those with a low level of miR-103. (B) DFS was compared between patients with HCC with a high expression level of miR-103 and those with a low level of miR-103. HCC, hepatocellular carcinoma; OS, overall survival; DFS, disease-free survival.